The latest quotation and buying guide of erdafitinib in 2024

Erdafitinib is an oral targeted drug specifically designed to treat patients with advanced or metastatic urothelial cancer. This type of cancer originates from the urinary system and involves the bladder, renal pelvis, and ureters. For patients who have received platinum-based chemotherapy and have FGFR2 or FGFR3 gene mutations, erdafitinib has demonstrated its unique therapeutic effect.

Although erdafitinib has not yet been officially launched in mainland my country, patients can purchase it through overseas markets. If you pursue the quality of the original drug, the Hong Kong version is the first choice. However, its price is as high as more than 20,000 yuan, and it needs to be purchased through specific pharmacies in Hong Kong. At the same time, foreign generic drugs provide more people-friendly choices, such as generic drugs from Laos and Bangladesh, with prices ranging from a few hundred yuan to more than 2,000 yuan. These drugs have roughly the same ingredients as the original drugs, so they have similar efficacy.

As a tyrosine kinase inhibitor, the core mechanism of action of Erdafitinib is to inhibit the activity of the FGFR (fibroblast growth factor receptor) family. FGFR is an important regulator of key biological processes such as cell growth, differentiation and angiogenesis. In some patients with urothelial cancer, abnormalities in the FGFR2 or FGFR3 genes can promote tumor growth. Erdafitinib inhibits the growth and spread of tumors by blocking these abnormal FGFR signals.

According to clinical trial data, erdafitinib has brought significant efficacy to some patients with advanced urothelial cancer. Patients treated with erdafitinib showed an advantage in overall survival and progression-free survival compared with chemotherapy.

But it’s important to note that any medication can cause side effects. Common side effects of erdafitinib include fatigue, nausea, vomiting, etc., and may cause eye problems due to inhibition of FGFR signals. Therefore, when using this drug, doctors need to make a comprehensive evaluation and pay close attention to the patient's reaction to the drug.